PARP-inhibitors in a non‐oncological indication as COVID-19: Are we aware about its potential role as anti-thrombotic drugs? The discussion is open-Reference-Cited by-同舟云学术

PARP-inhibitors in a non‐oncological indication as COVID-19: Are we aware about its potential role as anti-thrombotic drugs? The discussion is open

Published:2020-10 Issue: Volume:130 Page:110536
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Capoluongo Ettore

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference24 articles.

1. Virology, epidemiology, pathogenesis, and control of COVID-19;Jin;Viruses.,2020

2. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak;Rothan;J. Autoimmun,2020

3. The friendly use of chloroquine in the COVID-19 disease: a warning for the G6PD-deficient males and for the unaware carriers of pathogenic alterations of the G6PD gene;Capoluongo;Clin. Chem. Lab. Med.,2020

4. Coronavirus diseases (COVID-19) current status and future perspectives: a narrative review;Di Gennaro;Int. J. Environ. Res. Public Health,2020

5. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy;Tang;J. Thromb. Haemost.,2020

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk of thromboembolic events in patients with metastatic solid tumors treated with PARP inhibitors: A systematic review and meta-analysis of phase 3 randomized controlled trials;Cancer Treatment Reviews;2023-09

2. Repurposing and computational design of PARP inhibitors as SARS-CoV-2 inhibitors;Scientific Reports;2023-06-29

3. Assessment of Postvaccination Neutralizing Antibodies Response against SARS-CoV-2 in Cancer Patients under Treatment with Targeted Agents;Vaccines;2022-09-05

4. Immunological Response to COVID-19 Vaccination in Ovarian Cancer Patients Receiving PARP Inhibitors;Vaccines;2021-10-08

5. Role of Poly(ADP-ribose) Polymerase (PARP1) in Viral Infection and its Implication in SARS-CoV-2 Pathogenesis;Current Drug Targets;2021-09-07